PCA
TMO icon

Purkiss Capital Advisors’s Thermo Fisher Scientific TMO Stock Holding History

Purkiss Capital Advisors’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.49M Buy
4,961
+341
+7% +$164K 0.95% 25
2026
Q1 		$2.27M Buy
4,620
+466
+11% +$253K 1% 26
2025
Q4 		$2.41M Sell
4,154
-324
-7% -$183K 1.13% 18
2025
Q3 		$2.17M Buy
4,478
+1,023
+30% +$476K 1.04% 21
2025
Q2 		$1.4M Buy
3,455
+1,186
+52% +$496K 0.78% 27
2025
Q1 		$1.13M Buy
2,269
+114
+5% +$61.7K 0.85% 23
2024
Q4 		$1.12M Buy
+2,155
New +$1.18M 0.97% 22

Other funds holding TMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Purkiss Capital Advisors's TMO Position: Q2 2026 in Review

Purkiss Capital Advisors increased its Thermo Fisher Scientific (TMO) stake by 7.4% in Q2 2026, buying an estimated $164K and bringing the position to 4,961 shares worth $2.49M. The position accounts for 0.95% of the portfolio, ranked #25.

Purkiss Capital Advisors first reported a position in TMO in Q4 2024 and has held it in 7 quarters since. 2,620 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Purkiss Capital Advisors held 4,961 shares of Thermo Fisher Scientific worth $2.49M as of Q2 2026.
  • Purkiss Capital Advisors bought 341 Thermo Fisher Scientific shares in Q2 2026, an estimated $164K.
  • Thermo Fisher Scientific made up 0.95% of Purkiss Capital Advisors's portfolio in Q2 2026, its #25 holding.
  • Purkiss Capital Advisors first reported a position in Thermo Fisher Scientific in Q4 2024 and has held it in 7 quarters since.
  • 2,620 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Purkiss Capital Advisors's 13F filing for Q2 2026, filed 30 Jul 2026.